Benefits and Harms of Anticoagulants in People Hospitalized With COVID-19
Do anticoagulants reduce the risk of venous thromboembolism or mortality in people hospitalized with COVID-19?
Related Articles
Reducing Harms Associated with PSA Screening
American Family Physician Community Blog, Reducing Harms Associated with PSA Screening, written by Kenny Lin, MD, MPH.
April 2024
Articles Mandi Sehgal, Alexandra Sellers, Wendy S. Biggs Individuals’ impaired ability to hear and communicate may result in negative emotional, cognitive, economic, and social consequences.…
Coding & Documentation
E/M CODING FOR MULTIPLE MINOR INJURIES | TOBACCO DEPENDENCE AS CHRONIC CONDITION | BIRTH DEFECT DISCOVERED IN ADOLESCENCE | E/M SERVICE FOR PATIENT WITH IMPENDING…
Osteoporosis: Common Questions and Answers
Osteoporosis affects 10.2% of adults older than 50 years and is expected to increase to 13.6% by 2030. Osteoporotic fractures, specifically hip fractures, significantly affect…
Open Payments data available to review before it becomes public
Physicians have until May 15 to check data related to payments they’ve received from pharmaceutical and medical device companies and report any errors before the…
Fibromyalgia: Diagnosis and Management
Fibromyalgia is a chronic, centralized pain syndrome characterized by disordered processing of painful stimuli. Fibromyalgia is diagnosed more frequently in women and occurs globally, affecting…
Hypertensive Disorders of Pregnancy
Hypertensive disorders of pregnancy are a major contributor to maternal morbidity and mortality in the United States and include chronic and gestational hypertension, preeclampsia, HELLP…
Prescribing in the Nursing Facility: What Non-Nursing-Facility Doctors Need to Know
Having a basic knowledge of how nursing homes procure and administer medications can help you ensure your patients get theirs on time.